NorthRock Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,195
| Closed | -$214K | – | 827 |
|
|
2024
Q3 | $214K | Sell |
3,195
-1,148
| -26% | -$76.7K | 0.01% | 587 |
|
|
2024
Q2 | $516K | Buy |
4,343
+418
| +11% | +$49.6K | 0.02% | 333 |
|
|
2024
Q1 | $418K | Buy |
3,925
+638
| +19% | +$68K | 0.02% | 402 |
|
|
2023
Q4 | $327K | Buy |
+3,287
| New | +$327K | 0.01% | 433 |
|
|
2023
Q2 | – | Sell |
-1,681
| Closed | -$258K | – | 333 |
|
|
2023
Q1 | $258K | Sell |
1,681
-394
| -19% | -$60.5K | 0.03% | 258 |
|
|
2022
Q4 | $373K | Buy |
+2,075
| New | +$373K | 0.04% | 201 |
|
|
2022
Q3 | – | Sell |
-1,820
| Closed | -$260K | – | 321 |
|
|
2022
Q2 | $260K | Buy |
1,820
+254
| +16% | +$36.3K | 0.03% | 249 |
|
|
2022
Q1 | $270K | Buy |
1,566
+193
| +14% | +$33.3K | 0.02% | 261 |
|
|
2021
Q4 | $349K | Buy |
1,373
+455
| +50% | +$116K | 0.03% | 216 |
|
|
2021
Q3 | $396K | Buy |
+918
| New | +$396K | 0.03% | 181 |
|